DENISE JOHNSON ALLEN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ATHENS, GA NPI 1285826271
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family GA Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$2,386.48
- Category: General Payments
- Program years: PY2021–2024
- Record count: 112
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,036.64 across 38 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $946.65 | 37 |
| Education | $89.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $127.44 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $106.67 | 4 |
| Janssen Scientific Affairs, LLC | $88.60 | 1 |
| Daiichi Sankyo Inc. | $81.19 | 3 |
| EISAI INC. | $79.28 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $55.31 | 2 |
| Genentech USA, Inc. | $41.69 | 2 |
| EMD Serono, Inc. | $41.09 | 2 |
| Merck Sharp & Dohme Corporation | $39.54 | 2 |
| Tempus AI, Inc | $37.23 | 1 |
| GENZYME CORPORATION | $36.08 | 1 |
| Celgene Corporation | $35.51 | 2 |
| Karyopharm Therapeutics Inc. | $32.00 | 1 |
| Regeneron Healthcare Solutions, Inc. | $25.82 | 1 |
| Gilead Sciences, Inc. | $25.24 | 1 |
| JAZZ PHARMACEUTICALS INC. | $24.54 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $24.15 | 1 |
| Genmab U.S., Inc. | $22.72 | 1 |
| GlaxoSmithKline, LLC. | $21.72 | 1 |
| Lilly USA, LLC | $20.50 | 1 |
| Incyte Corporation | $19.68 | 1 |
| Agios Pharmaceuticals, Inc. | $18.36 | 1 |
| SERVIER PHARMACEUTICALS LLC | $17.07 | 1 |
| Rigel Pharmaceuticals, Inc. | $15.21 | 1 |
By program year
Records — PY2024 (38)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.